Advances in Lung Cancer Surgery

Dear Colleagues,

Currently, lung cancer treatment is changing owing to early detection achieved via computed tomography screening. Minimally invasive surgery has become widespread in thoracic surgery and is an established standard treatment for patients with early-stage lung cancer. Uniportal or robot-assisted thoracic surgery has drastically changed the conventional surgical approach in lung cancer surgery. An increasing number of innovations in thoracic surgery are focused on minimally invasive techniques, and can reduce the overall invasiveness experienced by the patients.

Among them, non-intubated thoracic surgery is an especially innovative anesthesia approach developed by Dr, Eugenio Pompeo, which can provide fast-track recovery after surgery. Widely spread minimally invasive approaches may be in the near future, combined with non-intubated thoracic surgery.

On the other hand, because of the limited available approaches in minimally invasive approaches, we often face some technical challenges, such as tumor localization. Localization of deeply located lung lesions remains to be challenging under minimally invasive thoracoscopic settings, and the rate of localization failure reportedly increases by up to 63%, when lesions are smaller than 10 mm or are located more than 5 mm from the pleural surface. Therefore, to overcome these difficulties, recently, a general thoracic team at Kyoto University developed a novel wireless localization technique using a radiofrequency identification microchip.

Thus, to overcome clinical issues, surgeons have generated innovative ideas and integrated new technology. However, because these techniques are relatively new, additional studies that improve its efficacy and safety will be required in the future.

The goal of this Special Issue entitled Advances in Lung Cancer Surgery is to share new insights into the latest techniques available for minimally invasive surgery, as well as the critical limitations or aspects that require improvement in the future. We welcome high-quality research papers with strong clinical impact regarding the latest topics in lung cancer treatment surrounding diagnostic approaches or surgery.

Dr. Yojiro Yutaka
Dr. Eugenio Pompeo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• minimally invasive surgery
• thoracic surgery
• minimally invasive thoracic surgery
• non-intubated video-assisted thoracoscopic surgery
• localization technique
• hybrid operation room
• bronchoscopy